SETH LERNER to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications SETH LERNER has written about Drug Screening Assays, Antitumor.
Connection Strength
0.076
-
Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urol Oncol. 2003 May-Jun; 21(3):197-205.
Score: 0.049
-
The preclinical activity of lenalidomide in indolent urothelial carcinoma. Anticancer Res. 2014 Jul; 34(7):3383-9.
Score: 0.027